OsteoRemedies LLC announced FDA clearance for expanded indications of its Spectrum GV dual antibiotic bone cement for the use in revision total hip arthroplasty procedures, according to a press release.The Spectrum GV bone cement, designed with dual antibiotic cement, is now indicated for component fixation during revision THA and two-stage revision THA after initial infection.
/PRNewswire/ OsteoRemedies® LLC, an orthopedic company focused on providing simple solutions to complex disorders, has announced FDA clearance for expanded.
Rose-Hulman Institute of Technology has launched its new, 10-year strategic plan, which focuses on themes that include sustainability and increasing college affordability.